AAPL 205.29 +0.06 (+0.03%)MSFT 129.1 -0.05 (-0.04%)FB 193.17 +0.16 (+0.08%)ZNGA 5.47 +0.01 (+0.28%)NVDA 182 -5.01 (-2.68%)WBA 52.66 +0.01 (+0.02%)GOOG 1263.45 -0.18 (-0.01%)PIH 5.25 -0.05 (-0.94%)
AAPL 205.29 +0.06 (+0.03%)MSFT 129.1 -0.05 (-0.04%)FB 193.17 +0.16 (+0.08%)ZNGA 5.47 +0.01 (+0.28%)NVDA 182 -5.01 (-2.68%)WBA 52.66 +0.01 (+0.02%)GOOG 1263.45 -0.18 (-0.01%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet APHB Quote AmpliPhi Bi

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 9 6 5
ShortTermInvest 0 0 0
Cash 9 6 5
AccountReceivab 0 0 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 10 6 5
PPE 2 2 2
AccumulatedDepr -1 -1 -1
NetPPE 1 1 1
EquityAndOtherI 0 0 0
Goodwill 8 0 0
IntangibleAsset 13 11 5
OtherLTAssets 0 0 0
TotalNonCurrent 21 12 6
TotalAssets 31 18 11
ShortTermDebt 0 1 0
AccountsPayable 1 2 1
TaxesPayable 0 0 0
AccruedLiabilit 0 0 0
DeferredRevenue 0 0 0
OtherCurrentLia 0 1 1
TotalCurrentLia 2 4 2
Debt 0 0 0
DeferredTaxesLi 3 2 1
DeferredRevenue 0 0 0
OtherLTLiabilit 13 2 0
TotalNonCurrent 16 5 1
TotalLiabilitie 19 8 3
CommonStock 0 0 0
AdditionalPaidI 375 391 402
RetainedEarning -363 -381 -394
AccumulatedOthe 0 0 0
TotalStockholde 13 10 8
TotalLiabilitie 31 18 11
AmpliPhi Biosciences Corporation income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AmpliPhi Biosciences Corporation FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.